IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — KVYO

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023
Cash & Equivalents0.830.980.980.940.890.830.790.760.72
Accounts Receivable0.080.070.060.060.050.030.030.020.02
Total Current Assets1.011.151.111.061.010.920.870.830.78
Property, Plant & Equipment0.090.080.070.060.050.050.040.040.04
Total Non-current Assets*0.380.380.360.340.340.280.280.280.29
Total Assets1.381.521.471.401.351.191.151.111.07
Accounts Payable0.040.020.020.020.010.010.010.010.01
Total Current Liabilities0.320.270.230.210.190.140.130.130.12
Total Non-current Liabilities*0.100.100.100.090.090.040.040.040.05
Total Liabilities0.420.370.320.300.280.180.170.170.17
Retained Earnings(0.88)(0.87)(0.88)(0.88)(0.86)(0.82)(0.82)(0.81)(0.77)
Total Stockholder Equity0.971.151.141.101.061.010.980.940.91

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total Revenue370.58358.01350.20310.88293.12279.83270.16235.09222.21209.99201.62175.81
Cost of Revenue101.4789.1197.4476.1471.2467.7071.7454.3650.2744.9445.0158.83
Gross Profit269.10268.89252.75234.74221.88212.13198.43180.74171.94165.06156.60116.98
Research & Development91.9380.0376.7372.6772.4669.3570.8655.7755.7456.1052.64141.46
Selling, General & Admin52.8353.0649.4345.2554.1243.0044.3938.2335.7639.1937.78109.85
Total Operating Expenses284.07267.15254.60245.57253.21235.88233.08194.02186.00187.15192.94419.19
Operating Income(14.96)1.75(1.85)(10.84)(31.33)(23.75)(34.65)(13.28)(14.05)(22.09)(36.33)(302.20)
Pretax Income(7.11)10.727.73(0.61)(22.48)(15.15)(24.58)(2.54)(4.08)(12.48)(26.89)(296.29)
Tax Provision1.741.680.70(0.19)1.80(1.07)2.40(1.20)0.860.40(0.59)0.82
Net Income(8.85)9.047.03(0.43)(24.28)(14.09)(26.97)(1.34)(4.94)(12.88)(26.29)(297.10)
Basic EPS(0.03)0.030.030.00(0.09)(0.05)(0.09)(0.01)(0.02)(0.05)(0.08)(1.24)
Diluted EPS(0.03)0.030.030.00(0.09)(0.05)(0.09)(0.01)(0.02)(0.05)(0.08)(1.24)

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Operating Cash Flow93.8834.2893.1654.7655.7314.3660.0938.7840.9026.1838.6480.73
Capital Expenditures6.5611.672.472.272.062.692.351.550.771.262.830.82
Free Cash Flow*87.3222.6190.6952.4953.6711.6857.7437.2440.1324.9235.8179.90
Investing Cash Flow(11.01)(15.72)(5.71)(9.74)(7.31)(7.74)(5.63)(4.54)(3.83)(3.22)(3.92)(5.43)
Financing Cash Flow(234.81)(98.85)(2.84)(0.27)(1.33)(0.04)0.23(0.98)0.69(5.74)(19.51)262.24

* Derived from reported values